POST DEXAMETHASONE PLASMA CORTISOL LEVELS IN DEPRESSIVES TREATED WITH IMIPRAMINE AND ELECTROCONVULSIVE THERAPY5 by Varma, S.L. et al.
Indian J. Psychial. (1989), 31(1), 78—82 
POST DEXAMETHASONE PLASMA CORTISOL LEVELS IN DEPRESSIVES 
TREATED WITH IMIPRAMIME AND ELECTROCONVULSIVE THERAPY
6 
S. L. VARMA
1 
J. K. TRIVEDI' 
MOHIM ANAND
3 
RAM GULAM
4 
NAROTTAM LAL
5 
SUMMARY 
Sixty patients of endogenous depression and thirty normal controls were studied to find out the rela-
tionship of post dexaini tlmsonc plasma Cortisol levels (PDPC) and clinical impiovcment of endogenous 
depression inpatients treated with electroconvulsive therapy and imipraminc. The PDPC levels in both 
the group of patientsshowedsiguificant decrease with clinical improvement (Pre and post treatment PDPC 
values nf V.t'.T group was _!0.7 iig,'dl and l'.l.fi ugjdl while it was 17.9 ug/dl and 12.7 ug|dl respectively for 
the Imipraminc group].. A significant correlation was also found between PDPC and scverily of illness 
(p<0.()OI) in the both groups which indicates that PDPC levels is independent of treatment moda-
lity used. 
The hist quarter of the century has 
seen biological psychiatry growing from its 
itifancv to a lolesr. Mice. A mo tg the many 
theories propounded about the ncuro-
biolog'cal mechanisms in major functional 
psvehoses, Dexatnuthasone Suppression 
Test (DST) has emerged to be the most 
promising otic. The piotver in t It is field 
was B. J. Carroll (1982) who along with 
M. Keiuberg, M. Steiner and co-workers 
had do lie illicit to stiidardise the test 
for use in psychiatry. 
DST lias been called a> laboratory 
marker of eulogenous depressed state 
(Carroll et al.. H)80\ Respon.se to DST is 
non suppressive during melancholia and 
suppressive during eutlivmia (Carroll, 
1972). Newer studies have suggested 
that DST m
:ght serve as an anci Diary 
index to predict clinical response and 
outcome of depression (Carroll et al., 
1968). The DST tends to normalize as 
depression subsides (Carroll, 1982 ; 
Ore den et al.. 1980) and may even nor-
malize well before clinical improvement 
which may have a predictive value for 
good treatment response. 
Coryell (1982) has predicted good 
ECT response when an abnormal DST 
was found at discharge. However, it was 
also .suggested that ECT may be affec-
ting hypothalamic structures which inva-
lidate its use as response predictor (Gru-
nhamsct al.. 1983). 
The PDPC levels have been used in 
monitoring of antidepressant treatment 
(Grcden et al., 1983). However, as the 
issue i? still controversial regarding the 
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utilisation of a uniform procedure for the 
measurement of PDPC and its use in de-
pressives treated with ECT and antide-
pressant drugs, we had planned a prospec-
tive study with the following aims : 
1. To assess the relationship of post 
dexamethasone plasma Cortisol levels and 
severity of depression in endogenous de-
pressives. 
2. To study the effect of treatment 
(ECT and Imipramine) and clinical res-
ponse on PDPC. 
Material and Methods 
The study was performed on an open 
parallel des'gn. The patients were ran-
domly assigned for treatment to either 
drugs or ECT. The patients of the ex-
perimental group comprised of 60 pati-
ents (drawn from the inpatient, Depart-
ment of Psychiatry, K. G's. Medical 
College, Lucknow) diagnosed as Manic 
Depressive Psychosis Depression (ICD-9, 
VVHOj and fulfilling the Research Diag-
nostic Criteria for major depression 
(Spitzer et al., 1978). The patients were 
between the age of 17-55 years and were 
evaluated on a preset selection criteria. 
The control group consisted of 30 normal 
subjects having no medical or psychiatric 
illness and matched for age and sex with 
the experimental group. They were eva-
luated clinically as well as on Cornell 
Medical Index (Broadman et al., 1949) to 
rule out psychiatric illness. The control 
group was taken to compare its values 
with that of depress ives 
The patients were evaluated on scree-
ning schedule, semistructured proforma, 
Research Diagnostic Criteria and Hamil-
ton Rating Scale for depression (HRSD) 
(Hamilton. I960] at the commencement 
of the study. An informed consent was also 
obtained from each patient and control. 
These patients were kept under observa-
tion for 7 clays (as a washout period of 
any drug taken,) and those patients whose 
HRS-D score was 17 or more on 7th day 
(day 0) were only included in the study. 
The patients of ECT group were 
given biweekly direct ECT's (direct 
ECT's were given to exlude the effect 
of drugs used in anaesthesia) upto a maxi-
mum of 10 treatments. However, the 
treatment was stopped when HRS-D levels 
fell to 5 or less. No extra medication 
was given apart from nitrazepam on SOS 
basis. The patients of the antidepressant 
group received a fixed dose of Imipramine, 
75 mg/day initially which was increased 
to 225 mg/day within a week. The drug 
was stopped when HRS-D fell to 5 or less. 
Weekly estimations of HRS-D and 
PDPC was done in both the groups. 
PDPC estimations was done by giving 
I mg of dexamethasone to the patient at 
II P. M. followed by sampling of blood at 
4 P.M. on the following day. The plasma 
was separated and PDPC levels estima-
ted by sepcu'otluorometric method 
(Mattingly, 1962). PDPC and HRS-D 
was estimated on Day 0 and there after 
every week on day 7, 14, 21, 28 and 35 
or stopped earlier when HRS-D score 
fell to 5 or less . Only one point PDPC 
was done on the control group. 
Results 
Sixty depressed and thirty controls 
were compared for PDPC values. The 
mean PDPC values of the depressed 
patients ('pre treatment) was 18.2±6.2 
/ig/dl (range 10.5-39.6; as compared to 
11.9 -i- 4.2 /ig/dl (range 7.2-19.5) 
that of controls. There was a signifi-
cantly higher PDPC values in depressed 
patients as cornpared to the controls. 
Thirty seven out of sixty patients had 
their first episode of depression while the 
rest had two or more episodes. 
When mean PDPC was compared 
in the male and female deprcssives it was 
found to be statistically non significant. 
The mean PDPC levels of the depressed BO S. L. VARMA et al. 
TABLE —Mean PDPC kuds in EGTand Impiramine group (figldl) 
Pre treatment 
Mean 
s.d. 
range 
Post t.ealmen) 
Mean 
s.d. 
range 
t 
P 
ECT 
Improved 
(N- -23) 
20.7 
6.2 
10.8-39.6 
•3.6 
2.6 
8.2- 18.8 
7.43 
<0.001 
g>'  oup 
Non improved 
(N-7) 
13.1 
1.8 
10.9-21.4 
11.3 
0.6 
9.1- 14.2 
2.3 
N.S. 
Impiramine 
Improved 
(N-19) 
17.9 
5.5 
10.5-27.3 
12.7 
4.1 
7.1-20.8 
5.13 
<0.001 
group 
Non improved 
(N—11) 
13.7 
1.5 
11.1-19.2 
11.8 
0.8 
8.7—12.8 
2.6 
N.S. 
patients ;u tin: begiuiug was U'.2±6.2 
Hg'dl (mire o gram p:v ili-.cilitrt:} (range 
10..")-3').f>
1 willl ihe corresponding HRS-D 
of 27.1 ').') (rang-: l
()-36i. There was 
s'g ufie.iul correlation found between 
PDPC levels and severity of illness, i.e. 
the PDPC tends to increase with increasing 
severity of illness (r: 0.71; p>0.001). 
The uv an PDPC levels in the, pa-
tie'Us treate.d with F,CT and those trea-
ted with luiipraiuiue. were fonnd to 
change significantly <>u clinical improve-
ment in their depressive status. Thus 
pre and posl treatment PDPC values in 
the l',CT in:.tied group was 20.7 /^g/dl 
and IS.tifig'dl ivsp.-etivrly. There was 
a siguilieaut decrease in the mean PDPC 
from 17.'i jig.'dl t>> 12.7 jig'dl in the 
Imipramini: group (Table . 
\o significant difference was found 
iu the l'DPC values of MDP-depiessed 
type and MDP eirculai eui'i'etltly de-
pressed  '0./' ,  patients  uprovi  with 
KCT's while h;i.:>"0 Jiowed improvement 
with antidepressant dings. The patient
1-' 
on FX1T showed quick recovery (50% 
improved within three weeks) as com-
pared to patients on Imipramine (37% 
improved within three weeks). This 
shows that patients on ECT tend to res-
pond faster than on pharmacotherapy. 
Another finding was the significant de-
crease of plasma Cortisol levels in the im-
proved group. 
Discussion 
The DST has been primarily investi-
gated as an aid in diagnosing endogenous 
depression, yet its major clinical use has 
been as a predictor of treatment response. 
It is commonly held that as abnormal 
DST predicts response to somatic thera-
pies. Gitlin and Garner (1986) reviewed 
16 published reports and found that 
DST predicted response to somatic 
therapies in only 6 of them. 
No difference could be detected in 
overall therapeutic improvement bet-
ween those patients with a normal or 
abnormal DST respectively based on 5 
ug'dl Cortisol cut off point used by Cop-
pen et id. (1985). However, when POST DEXAMETHLASONE PLASMA CORTISOL LEVELS  81 
they increased the cut off point to 10 
jLtg/dl it was found that patients having 
PDPC more than 10 /tg/dl rsesponded 
significantly better than those who had 
a normal DST response. This was found 
to be independent of the treatment 
modality used. Our findings are in 
agreement with the above study. The 
patients of the improved group had a 
higher mean PDPC as compared to the 
patients of the non improved group (The 
patients of the improved group had mean 
PDPC of 20. 7 and 17.9 Mg/dl in the EGT 
and Imipramine group respectively 
whereas the non improved had 13.1 and 
13.7 /xg/dl in thees two groups. 
The PDPC levels in the present sam-
ple was found to be significantly higher 
in depressed patients as compared to 
normal controls (p<0.001). This is in 
agreement with McGlure (1966), 
Carpenter and Bunney (1971), Carroll 
(1978), Verghese et al. (1973). However, 
Shopsin and Gershon (1971) could not 
find any difference in PDPC levelsin 
the depressives and controls. 
Several studies (McGlure, 1966 ; 
Goppen, 1967 and Sethi and Sethi, 1971) 
have reported that higher plasma Cortisol 
levels were found during hightened state 
depression thus indicating the increased 
of secretion of plasma Cortisol in severe 
depressives. Similar findings were observed 
in the present study when a significant 
correlation was found between PDPC 
levels and severity of depression . How-
ever, this is not universally accepted and 
some authors (Carroll and Davies, 1970 
and Verghese et al., 1973) had presented 
contradictory reports. 
Patients of the EGT treated group 
as well as, imipramine treated group 
showed significant improvement (Table) 
and a singificant decrease in PDPC 
values. This goes on to prove that PDPC 
is independent of the treatment modality 
used. 
As Galen and Gambino (1975) stat-
ed, "the monitoring of treatment is one of 
the most persuasive reasons for ordering 
a laboratory test", DST is all set to fulfil 
the above requirement in the years to 
come. 
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